Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis

Frank Sandmann(European Centre for Disease Prevention and Control), Marc Baguelin(Imperial College London), Lisa Domegan(Health Service Executive), Irina Kislaya(German Center for Infection Research), Jim McMenamin(Public Health Scotland), Jesús Castilla(Instituto de Salud Pública de Navarra), Diogo Marques(Public Health Scotland), Edwin van Leeuwen(Public Health England), D Lévy-Brühl(Santé Publique France), Sibylle Bernard-Stoecklin(Santé Publique France), Adam Meijer(National Centre for Infectious Diseases), Itziar Casado(Instituto de Salud Carlos III), Josie Murray(Public Health Scotland), Amparo Larrauri(Instituto de Salud Carlos III), Alin Gherasim(Instituto de Salud Carlos III), Ausenda Machado(National Institute of Health Dr. Ricardo Jorge), Clara Mazagatos(Instituto de Salud Carlos III), Joan O’Donnell(Health Service Executive), Richard Pebody(National Security Agency), Iván Martínez‐Baz(Instituto de Salud Carlos III), Baltazar Nunes(University of Lisbon), Mariëtte Hooiveld(Netherlands Institute for Health Services Research), Arlene Reynolds(Health Protection Scotland), Dominic Thorrington(Santé Publique France)
Vaccine
January 31, 2022
Cited by 23


Related Papers